Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

4869

LikeLikedUnlike

331-345 of 1225

Emerging Evidence: IgAN Disease-Modifying Agents
MinuteCE®
Emerging Evidence: IgAN Disease-Modifying Agents
- Richard Lafayette, MD, FACP
- Hong Zhang
1.00 program credits
The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
MinuteCE®
The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
- Richard Lafayette, MD, FACP
1.00 program credits
Emerging Therapies in IgAN: Who Could Benefit the Most?
MinuteCE®
Emerging Therapies in IgAN: Who Could Benefit the Most?
- Richard Lafayette, MD, FACP
- Hong Zhang
1.00 program credits
Mechanism-Based Targeting: Why APRIL Matters in IgAN
MinuteCE®
Mechanism-Based Targeting: Why APRIL Matters in IgAN
- Suzuki Yusuke, MD, PhD
- Dana Rizk, MD
1.00 program credits
Translating Guidelines to Action in IgAN: Embracing a Simultaneous Dual-Concordant Approach
MinuteCE®
Translating Guidelines to Action in IgAN: Embracing a Simultaneous Dual-Concordant Approach
- Richard Lafayette, MD, FACP
- Suzuki Yusuke, MD, PhD
1.00 program credits
APRIL Uncovered: An Upstream Driver in IgAN
MinuteCE®
APRIL Uncovered: An Upstream Driver in IgAN
- Dana Rizk, MD
- Hong Zhang
1.00 program credits
advertisement
IgAN SOC: Strengths and Limits
MinuteCE®
IgAN SOC: Strengths and Limits
- Dana Rizk, MD
- Suzuki Yusuke, MD, PhD
1.00 program credits
MinuteCE®
Inside the 4 Hits: Targeting APRIL to Change the Course of IgAN
- Richard Lafayette, MD, FACP
- Dana Rizk, MD
- Hong Zhang
- Suzuki Yusuke, MD, PhD
1.00 credits 9 episodes
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
CME/CE
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
- Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
- Amir H. Hamrahian, MD
0.25 credits
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
- Benjamin Levy, MD
0.25 credits
TKI: The New TKO for Retinal Diseases
MinuteCE®
TKI: The New TKO for Retinal Diseases
- Christina Y. Weng, MD, MBA, FASRS
- Katherine E. Talcott, MD
0.75 program credits
To Implant or to Inject?
MinuteCE®
To Implant or to Inject?
- Katherine E. Talcott, MD
- Roger A. Goldberg, MD, MBA
0.75 program credits
advertisement
Who Needs a TKI? Identifying the Right Candidates
MinuteCE®
Who Needs a TKI? Identifying the Right Candidates
- Roger A. Goldberg, MD, MBA
- Christina Y. Weng, MD, MBA, FASRS
0.75 program credits
MinuteCE®
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
- Katherine E. Talcott, MD
- Christina Y. Weng, MD, MBA, FASRS
- Roger A. Goldberg, MD, MBA
0.75 credits 5 episodes
The Struggle Is Real
MinuteCE®
The Struggle Is Real
- Katherine E. Talcott, MD
- Roger A. Goldberg, MD, MBA
0.75 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended